by 21st Century Competition | May 21, 2014 | Global Blogs
AstraZeneca’s decision not to engage in possible merger discussions with pharmaceutical rival Pfizer even after an offer upped to $119 billion has caused a riff between AstraZeneca shareholders, reports say. Significant shareholders of the UK pharmaceutical firm...
by 21st Century Competition | May 21, 2014 | Global Blogs
The European Commission has declined to hear a complaint about the UEFA Champions League new rule of Financial Fair Play, reports say. According to a source, the Commission rejected the complaint, which was the only one filed against the FFP rule, which limits the...
by 21st Century Competition | May 21, 2014 | Global Blogs
The NCAA continues to seek ways to have an antitrust trial against the association delayed despite having earlier requests to do so denied. This time, reports say, the NCAA wants the trial put off until February. The trial, set to begin next month, was filed by...
by 21st Century Competition | May 21, 2014 | Global Blogs
European Commissioner Joaquin Almunia responded to remarks made only days ago by Germany Economy Minister Sigmar Gabriel, who argued that a forced breakup of Google should be “seriously considered” due to its overwhelming market power. Such a breakup could not be...
by 21st Century Competition | May 21, 2014 | Global Blogs
While opposition to AT&T’s recently announced plans to acquire cable giant DirecTV in a $48.5 billion deal has already surfaced, few members of the opposition are likely to succeed in blocking the merger. But according to reports, there is one entity that...
by 21st Century Competition | May 21, 2014 | Global Blogs
May 21, 2014 Earlier today, the Competition Bureau posted new remarks by the Commissioner of Competition from the Canadian Bar Association’s 2014 Competition Law Spring Forum (one of two annual Canadian competition law conferences hosted by the CBA). See:...
